FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media PR Newswire HOUSTON, Sept. 1...
PR Newswire
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial PR Newswire HOUSTON, Aug. 27, 2026 HOUSTON, Aug. 27, 2026 /PRNewswire...
PR Newswire
FibroBiologics Regains Compliance with Nasdaq Trading Rules
FibroBiologics Regains Compliance with Nasdaq Trading Rules FibroBiologics Regains Compliance with Nasdaq Trading Rules PR Newswire HOUSTON, Aug. 26, 2026 HOUSTON, Aug. 26, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology...
PR Newswire
FibroBiologics Appoints Leigh Steinberg to Board of Directors
FibroBiologics Appoints Leigh Steinberg to Board of Directors FibroBiologics Appoints Leigh Steinberg to Board of Directors PR Newswire HOUSTON, Aug. 24, 2026 Legendary Sports Agent, Attorney, and Longtime Advocate for Human Longevity and Brain Health Joins BoardHOUSTON, Aug. 24, 2026 /PRNewswire...
PR Newswire
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease PR Newswire HOUSTON, Aug. 20, 2026...
PR Newswire
FibroBiologics Says Preclinical Data Shapes Design of Further Studies for Degenerative Joint Treatment
FibroBiologics reports promising preclinical results for a novel joint repair therapy, offering a faster, scalable alternative to surgery.read more...
Benzinga
FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints
FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints PR Newswire HOUSTON, Aug. 18, 2026 Animal trials show...
PR Newswire
FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets
FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets PR Newswire...
PR Newswire
FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage
FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage PR Newswire HOUSTON, Aug. 5, 2026 Granted claims cover Sox9-based conversion of fibroblasts into...
PR Newswire
FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate PR Newswire HOUSTON, July 31, 2026 - First...
PR Newswire